The bill establishes a single, national Medicare‑for‑All insurance program that covers every U.S. resident (with the Secretary setting residency rules), issues a Universal Medicare card, and phases in benefits over a two‑year transition (with some age‑based early eligibility). It defines an explicit, broad benefits package (hospital, primary, mental health, reproductive care including abortion and ART, gender‑affirming care, oral/vision/audiology, and expanded long‑term services) and bans cost‑sharing, balance billing, prior authorization and step therapy.
To pay for and manage care the Secretary must set a National Health Budget and regional allotments, negotiate global budgets with institutional providers, establish a national fee schedule for other clinicians, and annually negotiate drug prices — including a backstop that can authorize competitive licensing if negotiations fail. The bill also includes detailed provider participation rules, whistleblower protections, reporting requirements, new offices for health equity and primary care, and a transitional buy‑in option one year after enactment.
At a Glance
What It Does
Creates a single federal health insurance program that entitles all U.S. residents to a comprehensive, no‑cost benefits package, eliminates duplicate private coverage, and reorganizes provider payment into global budgets for institutions and a national fee schedule for clinicians.
Who It Affects
All U.S. residents (automatic enrollment at birth/residency); hospitals, clinics and clinicians required to sign participation agreements; private insurers and employers barred from selling duplicate benefits; pharmaceutical manufacturers subject to annual price negotiations and a competitive‑license fallback.
Why It Matters
This is an across‑the‑board redesign of financing and delivery: it removes point‑of‑service charges, replaces insurer billing with public global budgets and a trust fund, forces price discipline on drugs and devices, expands long‑term and reproductive care, and imposes extensive reporting, ethics, and staffing rules on providers.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill sets up a single, national insurance program administered by HHS that guarantees medically necessary care to every U.S. resident. The Secretary must define residency rules, run enrollment (including automatic enrollment at birth or on establishing residency), and issue a Universal Medicare card that expressly excludes Social Security numbers.
Benefits begin generally two years after enactment, with targeted earlier coverage windows for certain age groups; a transitional buy‑in is available through the Exchanges starting one year after enactment.
Coverage is comprehensive and explicit: inpatient and outpatient hospital care (including emergency and inpatient drugs), primary/preventive care, mental health and substance‑use services, reproductive services (including abortion, contraception and ART), gender‑affirming care, oral/vision/audiology, hospice, and a broad new entitlement to long‑term services and supports (prioritizing home‑and‑community‑based care and self‑direction). The bill forbids cost‑sharing, balance billing, prior authorizations and step therapy for covered services, and requires the Secretary to review and recommend benefit improvements annually.Providers must meet State licensure and national minimum standards, sign participation agreements, comply with uniform reporting, and follow a statutory duty of ethics that bars employment or compensation structures tied to utilization or profit.
Institutional providers negotiate quarterly‑reviewed global budgets with regional directors; certain clinicians may be salaried from those budgets, otherwise a national fee schedule applies. The national health budget separates operating, capital, special projects, quality, education, admin, reserves and targeted workforce assistance.The bill makes HHS the central purchaser of drugs, requiring annual price negotiations and — if talks fail — empowering the Secretary to authorize competitive licenses to use patents or data with a prescribed compensation framework for innovators.
It creates an Office of Health Equity and an Office of Primary Care, mandates uniform data reporting and a centralized repository, and establishes a Beneficiary Ombudsman and regional offices to manage access, capital planning and quality oversight.Transition provisions eliminate the 24‑month Medicare waiting rule for people with disabilities, require continuity‑of‑care protections during the phase‑in, and forbid private insurers or employers from offering coverage that duplicates Medicare‑for‑All after the program’s effective date. ERISA and other statutes are amended to prevent duplicative employer benefits and to require coordination with workers’ compensation.
The Five Things You Need to Know
Universal enrollment and a Universal Medicare card: Secretary must auto‑enroll newborns and new residents and issue identification cards that do not include Social Security numbers.
No patient cost‑sharing and no balance billing: the law bans deductibles, copays, coinsurance, balance bills, prior authorization, and step therapy for covered services.
Global budgets for institutions: hospitals and other institutional providers negotiate quarterly‑reviewed global budgets with regional directors; global budgets are intended to be payment in full for operating expenses.
Competitive licensing fallback for drugs: if annual price negotiations fail the Secretary can authorize use of patents or data to enable alternate manufacturing under a compulsory license with ‘reasonable compensation’ set by the Secretary.
Private duplicates prohibited and private contract penalties: starting on the effective date private insurers and employers may not sell duplicate coverage; participating providers who enter illicit private contracts risk voided contracts and a two‑year payment ban.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Establishment, universal eligibility and enrollment
These sections create the Medicare for All Program, require the Secretary to define residency for eligibility, and mandate automatic enrollment at birth or upon establishing residency. The Universal Medicare card is to be issued at enrollment and must not display a Social Security number. The effective date for benefits is generally 2 years after enactment, with a 1‑year early availability window for people under 19 and people 55 and older; the Secretary may allow transitional buy‑ins before full effect.
Comprehensive benefits and utilization rules
The bill defines a broad, explicit benefits package and requires the Secretary to review it annually; recommendations may add but not eliminate benefits. It prohibits all forms of patient cost‑sharing, bans balance billing, and removes prior authorization and step therapy requirements for covered items. The Secretary must issue national coverage determinations for experimental services and set an appeals process modeled on current Medicare rules.
Long‑term services and supports entitlement
Long‑term services become an entitlement based on medically determinable conditions causing functional limitations; the statute prioritizes home‑and‑community‑based services, mandates person‑centered assessments and self‑direction options, and requires an advisory commission (including people with disabilities) to help define scope and standards. Budgeting and payments for these services are brought into the national health budget framework.
Provider participation, ethics, and private contracts
Providers must meet State licensure, sign participation agreements, comply with uniform reporting, and follow a duty of ethics that forbids incentive structures tied to utilization. The statute bans participating providers from private contracts for covered services; tightly constrained private contracts are allowed for noncovered items with signed disclosures and affidavits, and serious sanctions apply for abuses, including voiding contracts and multi‑year payment penalties.
National health budget, global budgets, and payment rules
HHS must set an annual National Health Budget divided into operating, capital, special projects, education, quality, administrative, and reserve components, and allocate regional allotments. Institutional providers negotiate global budgets with regional directors using historical volumes, comparative payment rates and adjustments for staffing and capacity; global budgets are payment in full for operating expenses. Non‑institutional clinicians are paid from a national fee schedule established within a year; capital and special projects funding are separately administered with prioritization for underserved areas.
Drug pricing and competitive licensing fallback
The Secretary negotiates prices for covered drugs annually and may finalize negotiated prices before each fiscal year. If negotiations fail, the Secretary can authorize competitive licensing to enable manufacture under a license while setting reasonable compensation to the original manufacturer; the law contemplates prioritized FDA review for such products and prohibits anticompetitive tactics to frustrate licensing.
Financing, trust fund and transition mechanisms
The Universal Medicare Trust Fund is established; initial funding includes transfers of amounts previously spent in federal programs (Medicare, Medicaid, FEHB, TRICARE purchased care, etc.) and appropriations equal to specified revenue increases tied to tax and other amendments. A two‑year transition framework and a one‑year‑in Medicare transition buy‑in through the Exchanges are specified; the bill also eliminates the SSDI 24‑month Medicare waiting period.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Previously uninsured and underinsured residents — gain entitlement to comprehensive care with no cost‑sharing and guaranteed access to services including reproductive and gender‑affirming care.
- People needing long‑term services and supports — the bill creates an entitlement prioritizing home‑and‑community‑based care, uniform eligibility assessments, and options for self‑direction.
- Low‑income individuals and medically underserved communities — prioritized capital and special‑project funding, no out‑of‑pocket costs, and an Office of Health Equity focused on disparities.
Who Bears the Cost
- Private insurers and insurance shareholders — barred from selling duplicate benefits and likely to lose large portions of the market or be compelled to offer non‑duplicative supplemental plans.
- Employers that currently sponsor group health plans — prohibited from offering duplicate coverage, creating adjustment costs and potential HR/benefit redesign expenses.
- Hospitals and health systems — must accept global budgets and new reporting/staffing rules; they face revenue model changes, capital‑allocation controls, and restrictions on profit distribution.
- Pharmaceutical and medical device manufacturers — face annual government price negotiation and a compulsory licensing backstop that can reduce pricing leverage; may see downward pressure on revenues.
- State and local governments — although federal funding absorbs many costs, States may face administrative shifts and decisions about optional supplemental benefits and local workforce adjustments.
Key Issues
The Core Tension
The bill’s central dilemma is between guaranteeing comprehensive, no‑cost medical and long‑term care to everyone and constraining system costs by removing market‑based pricing and profit incentives. Tools that control spending (global budgets, price negotiation, and licensing backstops) enable universal coverage but can also dampen provider margins, investment incentives, and manufacturer revenues — risking access, innovation, and provider participation unless budget-setting, transition funding, and operational safeguards are carefully calibrated.
Financing and fiscal sufficiency are central and under‑specified risks. The bill directs transfers from existing federal health programs and authorizes appropriations tied to revenue increases, but it leaves many details (tax rates, specific revenue sources) outside this text.
The program’s ability to sustain comprehensive, no‑cost coverage depends on the Secretary’s annual budgetary allocations, the method for estimating and capturing the ‘net increase in revenues,’ and the political and legal durability of those funding streams.
Payment reforms create real trade‑offs. Global budgets realign institutional incentives toward population management and cost control and include mechanisms (quarterly review, interim adjustments) to respond to shocks.
But global budgets and a prohibition on incentive‑based compensation risk reducing supply or dampening innovation at the facility level unless budgets sufficiently reflect staffing needs and technology costs. The compulsory licensing fallback for drugs protects access but raises complex IP, trade, and R&D‑incentive issues and invites litigation and international pushback.
Implementation burdens — standardized national reporting, new regional structures, capital allocation rules and mandatory staffing minima — impose operational and administrative costs that could strain smaller or rural providers if funding and transition supports are insufficient.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.